Ebastine/pseudoephedrineAlternative Names: Ebastine/pseudoephedrine hydrochloride; EBPS; Pseudoephedrine hydrochloride/ebastine; Pseudoephedrine/ebastine; Rino-Ebastel
Latest Information Update: 19 Mar 2014
At a glance
- Originator Almirall S.A.
- Class Antiallergics; Biphenyl compounds; Butyrophenones; Decongestants; Piperidines; Propanolamines; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Histamine H1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic rhinitis
Most Recent Events
- 31 Dec 2012 Launched for Allergic rhinitis in Spain (PO)